Good MorningInvestors remained cautious Tuesday ahead of Friday’s inflation data and updates on trade and tariffs. The S&P 500 hovered within a tight range near break-even and below the critical 150-day exponential moving average (EMA).
The 150-day EMA is key because it reflects long-term investor sentiment and often acts as a support or resistance level in broader market trends. Given the proper catalyst, a market below the EMA is ready to sell. Bad news regarding tariffs or inflation could be the catalyst this week. Featured: This Single Fund Owns Every Major AI Stock and Pays Weekly (Ad) 
|
Markets | |
Many exchange-traded funds (ETFs) offer competitive annual fees—the influx of hundreds of new products to the space in recent years has driven expense ratios for many types of funds downward in a bid to attract investors.
Most investors looking at the ETF market will not settle for a modera... Read the Full Story |
|
From Our Partners | | Palantir, Micron and SanDisk show how fast a stock can become the trade everyone suddenly wants. That's often when investors make their costliest mistake: arriving after the easy part of the move is gone.
A new premium eBook flags 7 stocks that may be worth knowing about before the broader crowd catches on. You don't need to buy any of them - just knowing what's quietly gaining attention can be useful. | | See the 7 stocks on the watchlist while it's still free |
|
Markets | | Every year, more U.S. cities roll up their sleeves to back the dreamers and doers launching startups.
Our survey of the top 150 startup-friendly cities - based on local government support - shows just how widespread this trend has become.
From heavyweights like Dallas and New York City to smalle... Read the Full Story |
|
Technology | |
NVIDIA (NASDAQ: NVDA) insiders are selling in Q1 2025, and it poses no threat to the market. The insider selling has not only subsided to a multi-year low, but the sales are small and align with share-based compensation trends.
NVIDIA insiders, including board members, get restricted stock unit... Read the Full Story |
|
From Our Partners | | More than 25 candidates were screened for share price between $1 and $5, market cap above $100 million, daily volume over 500,000 shares, and over $10 million in trailing revenue.
Only five stocks cleared every filter, spanning five different sectors. Two are profitable today, and one pays a substantial dividend.
The report also flags what could go wrong with each pick, including dilution and convertible debt. | | See the five stocks that survived this strict revenue screen |
|
Consumer Staples | |
In a market obsessed with the next big growth story, it’s easy to overlook the quiet power of consistency. As tariff turbulence continues, some investors are diverting a portion of their portfolio funds to dividend stocks, which both provide immediate income and traditionally show less volat... Read the Full Story |
|
Industrials | |
Last year was a breakout period for the space industry, with several small-cap space stocks surging in value and transitioning into mid-cap status, attracting retail and institutional investors.
However, 2025 has brought a stark contrast, as risk aversion in U.S. equities has led to sharp decline... Read the Full Story |
|
|
Utilities | |
Oklo’s (NYSE: OKLO) stock price is melting down and may head even lower before the bottom is found, opening up the buying opportunity savvy investors have been waiting for. Up more than 110% at its peak in early 2025, the stock price is now back at reasonable levels where serious growth in... Read the Full Story |
|
Energy | |
Insider buying picked up for Matador Resources (NYSE: MTDR), Tenaya Therapeutics (NASDAQ: TNYA), and FirstSun Capital Bancorp (NASDAQ: FSUN) in March. These companies rank high, if not in first position, for the number of insiders buying, the number of shares purchased, and the dollar amount spent... Read the Full Story |
|
Healthcare | |
The biotechnology sector has experienced a jolt of volatility over the past few days, spearheaded by the dramatic price surges in Tonix Pharmaceuticals (NASDAQ: TNXP) and Lexeo Therapeutics (NASDAQ: LXEO). The biotech industry is known for its volatile price swings, often influenced by clinical tr... Read the Full Story |
|
Finance | |  Read the Full Story
|
|
Materials | |
Gold prices have been hitting all-time highs recently, surging through $3,050 per ounce in March 2025. Fears of trade wars spurred on by the Trump tariffs are causing a flight to safety and a mad rush into gold, with price up 15% year-to-date (YTD) as tracked by the SPDR Gold Shares ETF (NYSEARCA:... Read the Full Story |
|
Wednesday's Early Bird Stock Of The Day The YieldMax SNOW Option Income Strategy ETF (SNOY) is an exchange-traded fund that mostly invests in information technology equity. The fund seeks to provide current income and capped gains on the Snowflake stock (SNOW) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. SNOY was launched on Jun 10, 2024 and is issued by YieldMax. | | View Today's Stock Pick |
|
